Article
Drp1-Mediated Mitochondrial Metabolic Dysfunction Inhibits the Tumor Growth of Pituitary…
Oxidative Medicine and Cellular Longevity · 2021 · Kexia Fan, author Xiao Ding, author Zhenle Zang, author Yin Zhang, author Xiaoshuang Tang, author Xiangdong Pei, author Qingbo Chen, author Huachun Yin, author Xin Zheng, author Yong Chen, author Song Li, author Hui Yang, author Ferdinando Chiaradonna, Academic Editor
Key facts
| Title | Drp1-Mediated Mitochondrial Metabolic Dysfunction Inhibits the Tumor Growth of Pituitary Adenomas |
|---|---|
| First author | Kexia Fan, author Xiao Ding, author Zhenle Zang, author Yin Zhang, author Xiaoshuang Tang, author Xiangdong Pei, author Qingbo Chen, author Huachun Yin, author Xin Zheng, author Yong Chen, author Song Li, author Hui Yang, author Ferdinando Chiaradonna, Academic Editor |
| Journal | Oxidative Medicine and Cellular Longevity |
| Published | Aug 5, 2021 |
| DOI | 10.1155/2022/5652586 |
| Devices mentioned | BK110039, DEN000008, K022086, K103302, K810863, K852441, K854177, K854178, K854179, K854180, K854181, K854182 and 8 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, DBM, JLX and 12 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1